OBJECTIVES: Although the number of elderly patients undergoing combined aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) is increasing, the early and mid-term outcomes of this combined procedure remain to be determined. We sought to elucidate the early and mid-term outcomes of elderly (≥75 years) vs non-elderly (<75 years) patients who underwent combined AVR and CABG.
INTRODUCTION
The number of elderly patients undergoing aortic valve replacement (AVR) is increasing, and a significant proportion of them have concomitant coronary artery disease. When patients undergoing AVR have severe or critical coronary artery disease, concomitant coronary artery bypass grafting (CABG) is necessary to avoid perioperative myocardial infarction. Several studies reported that concomitant CABG was performed in more than half of elderly patients undergoing AVR [1, 2] . The differences in outcomes in elderly patients undergoing AVR with and without CABG remain unclear. It has been suggested that concomitant CABG is a risk factor in elderly patients undergoing AVR. Some studies reported higher rates of operative mortality and morbidity in elderly patients after combined AVR and CABG compared with AVR alone [2] [3] [4] [5] [6] . In contrast, other studies reported similar outcomes after AVR with or without CABG [7] [8] [9] . All these studies reported comparisons between AVR alone vs combined AVR and CABG in elderly patients. To the best of our knowledge, few studies have compared elderly and non-elderly patients who underwent combined AVR and CABG.
The aim of this study was to compare early and mid-term outcomes in elderly (≥75 years) vs non-elderly (<75 years) patients who underwent combined AVR and CABG.
Institute, including 155 elderly patients (59.8%; Elderly group) with a mean age of 79.8 ± 3.6 years and 104 non-elderly patients (40.2%; Non-elderly group) with a mean age of 67.3 ± 5.8 years. Preoperative characteristics of the patients are summarized in Table 1 . The Elderly group had a higher proportion of female patients than the Non-elderly group. Patients in the Elderly group had a lower mean weight and were more likely to have a history of congestive heart failure and smoking than those in the Non-elderly group. The aetiologies of valve diseases are summarized in Table 1 . Patients who underwent concomitant valve surgery other than AVR or aortic surgery were excluded from the study. Our surgical strategy was to perform complete revascularization if possible, and this was achieved in 94.8% of patients in the Elderly group and 98.1% of patients in the Non-elderly group (P = 0.324). Coronary angiography was performed in all patients, and a >50% stenosis was considered significant.
The Institutional Review Board of our institute approved this retrospective study and waived the need for written consent from the patients. Follow-up was by direct communication with one or more of the patients, the patient's family and the patient's attending physician.
Surgery and postoperative anticoagulation
Median sternotomy was performed in all patients. Cardiopulmonary bypass was established with ascending aortic and right atrial cannulation. A left ventricular vent was placed through the right upper pulmonary vein. Cardiac asystole was achieved with a combination of antegrade and retrograde blood cardioplegia. The diseased valve was excised, and if the annulus was calcified, it was carefully debrided of calcium deposits with a rongeur or Cavitron Ultrasonic Surgical Aspirator (CUSA; Tyco Healthcare, Mansfield, MA, USA). After excision of the aortic valve, the distal anastomoses between the coronary arteries and grafts were performed, except for the anastomosis between the left internal thoracic artery and the left anterior descending artery. The aortic valve prosthesis was implanted using non-everting mattress sutures or simple interrupted sutures. Proximal anastomoses between the aorta and the coronary artery grafts were performed after the closure of the aorta. After the aorta was declamped, the left internal thoracic artery was grafted to the left anterior descending artery with the heart beating. Valve selection was done according to the preference of the surgeon or the patient.
Management in the intensive care unit (ICU) was similar between the two groups. Aspirin and warfarin were started after surgery if not contraindicated. In patients with a biological valve, warfarin was discontinued 3 months after surgery unless there was a reason for continued anticoagulation, such as atrial fibrillation. In patients with a mechanical valve, warfarin was continued with the international normalized ratio measured monthly and maintained between 2.0 and 2.5.
Definitions
Non-elective operations included both emergency and urgent cases according to the definitions of the Society of Thoracic Surgeons. Operative death was defined as death during the same hospitalization, or after hospital discharge but within 30 days of the procedure. Postoperative low-output syndrome was defined as the need for intra-aortic balloon pumping, any dose of adrenaline or >5 µg/kg/min of dopamine or dobutamine. Perioperative myocardial infarction was defined as new Q-waves on electrocardiography or a peak creatine kinase-MB level of greater than or equal to five times the upper limit of normal (25 IU/l). Postoperative respiratory failure was defined as the need for prolonged ventilation (>48 h) or a diagnosis of pneumonia. Postoperative stroke was defined as a new stroke confirmed by computed tomography findings. In patients with preoperative stroke, postoperative stroke was defined as a worsening of the neurological deficit with new radiological findings. Early major complications included re-exploration due to bleeding, lowoutput syndrome, perioperative myocardial infarction, severe ventricular arrhythmia, requirement for haemodialysis, stroke and mediastinitis. Major adverse valve-related events included valve-related mortality, all valve-related morbidity and need for new permanent pacemaker or defibrillator within 14 days after the operation according to the guidelines for reporting mortality and morbidity after cardiac valve intervention [10] .
Statistical analysis
Continuous variables are reported as mean ± standard deviation. Continuous variables were compared using Student's t-test (or the Mann-Whitney U-test when appropriate), and discrete variables were compared using the χ 2 test or Fisher's exact test. Univariate and multivariate logistic regression analyses were performed to identify the significant predictors of early major complications. Actuarial survival curves were estimated using the Kaplan-Meier method. The log-rank test was used to assess the significance of differences in survival between groups. Univariate and multivariate Cox proportional hazards analyses were performed to identify the significant predictors of late mortality and morbidity, using the clinical variables listed in Table 1 . Age and the variables with P < 0.1 in univariate analyses were included in the multivariate model. Differences were considered statistically significant at P < 0.05. Statistical analyses were performed using the StatView 5.0 software package (SAS Institute, Inc., Cary, NC, USA).
RESULTS

Early outcomes
Operative data are summarized in Table 2 . The mean number of distal anastomoses was not significantly different between the Elderly and Non-elderly groups. The left anterior descending artery was the most frequent target vessel for revascularization in both groups, and the internal thoracic artery was used in 74% of patients in both groups. Bilateral internal thoracic arteries were used more frequently in the Non-elderly group than in the Elderly group, but this difference was not significant. In both groups, the internal thoracic artery was grafted to the left anterior descending artery in almost all patients.
A biological valve was used more frequently in the Elderly group than in the Non-elderly group. However, the mean size of the prosthetic valve was not significantly different between the two groups. Aortic cross-clamp time, cardiopulmonary bypass time and operation time were not significantly different between the two groups. Blood transfusion was more frequent in the Elderly group than in the Non-elderly group.
Postoperative data are presented in Table 3 . The operative death rate, postoperative intubation time and ICU stay were not significantly different between the two groups. In the Elderly group, operative deaths were caused by mediastinitis in 1 patient, low-output syndrome in 1 and multiorgan failure in 1. In the Non-elderly group, operative death was caused by pneumonia in 1 patient. There were no significant differences in the rates of postoperative complications between the two groups, except for re-exploration due to bleeding. Univariate analyses identified the associations between early major complications and prior myocardial infarction, lower ejection fraction, number of diseased vessels, left main coronary artery disease, previous percutaneous coronary intervention, history of congestive heart failure, diabetes mellitus, history of smoking, higher creatinine level, non-elective operation and EuroSCORE II. Multivariate analyses identified only history of congestive heart failure as an independent predictor of early major complications (odds ratio 2.729, 95% confidence interval 1.028-7.248, P = 0.044). Age was not an independent predictor of early major complications.
Mid-term outcomes
The overall completeness of follow-up was 99.2% (2 patients were lost to follow-up). It was 98.7% in the Elderly group and 100% in the Non-elderly group. The total follow-up time was 422 patientyears in the Elderly group and 320 patient-years in the Non-elderly group. The mean follow-up times were 33.1 ± 21.7 (median 30.3) months in the Elderly group and 37.4 ± 22.2 (median 36.7) months in the Non-elderly group. 
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The rates of 5-year freedom from all-cause death were 83.1 ± 4.8% in the Elderly group and 87.2 ± 5.2% in the Non-elderly group (Fig. 1A) , which was not a significant difference between the two groups. Univariate analyses identified associations between 5-year all-cause death and New York Heart Association functional class, ejection fraction, congestive heart failure, diabetes mellitus, creatinine level, non-elective operation and EuroSCORE II. Multivariate analyses identified diabetes mellitus, creatinine level and EuroSCORE II as independent predictors of 5-year all-cause death (Table 4) . Age was not an independent predictor of 5-year all-cause death.
Mid-term survival compared with the age-and gendermatched normal Japanese population for each group is shown in Supplementary Fig. 1 .
The rates of 5-year freedom from cardiac death were 92.3 ± 2.7% in the Elderly group and 94.8 ± 3.4% in the Non-elderly group (Fig. 1B) , which was not a significant difference between the two groups. Univariate analyses identified associations between 5-year cardiac death and ejection fraction, previous percutaneous coronary intervention, creatinine level, non-elective operation and EuroSCORE II. Multivariate analyses identified previous percutaneous coronary intervention as the only independent predictor of 5-year cardiac death (Table 5) . Age was not an independent predictor of 5-year cardiac death.
The rates of 5-year freedom from stroke were 94.0 ± 2.6% in the Elderly group and 99.0 ± 1.0% in the Non-elderly group (Fig. 1C) , which was not a significant difference between the two groups. Univariate analyses identified no associations between 5-year stroke and any of the variables tested, including age. There were 2 patients with cerebral haemorrhage during follow-up in the Non-elderly group. There was no patient with cerebral haemorrhage in the Elderly group. However, this difference did not reach statistical significance (P = 0.160).
The rates of 5-year freedom from major adverse valve-related events were 90.0 ± 3.5% in the Elderly group (linearized rate 2.0% per patient-year) and 93.1 ± 2.8% in the Non-elderly group (linearized rate 2.4% per patient-year; Fig. 1D ), which was not a significant difference between the two groups. Univariate analyses identified associations between 5-year major adverse valve-related events and body surface area, diabetes mellitus and creatinine level. Multivariate analyses identified creatinine level as the only independent predictor of 5-year major adverse valve-related events (Table 6 ). Age was not an independent predictor of 5-year major adverse valve-related events.
DISCUSSION
The results of the present study show that early and mid-term outcomes after combined AVR and CABG were almost the same in elderly and non-elderly patients. Furthermore, age was not an independent risk factor for late death in patients undergoing combined AVR and CABG. Previous studies reported that almost half of the patients undergoing AVR also needed CABG [1, 2] . Elderly patients undergoing AVR were more likely to require CABG than non-elderly patients undergoing AVR [2] . However, it has been suggested that combined AVR and CABG in elderly patients have increased risks compared with AVR alone [2] [3] [4] [5] [6] . Kolh et al. [5] reported that, in elderly patients who underwent combined AVR and CABG, the early postoperative mortality rate was 24% and the late postoperative mortality rate was 10%, after a mean follow-up period of 58.2 months. They speculated that the prolonged ischaemic time associated with multiple revascularization grafts in patients undergoing AVR may not be appropriate in elderly patients. More recently, Langanay et al. [11] reported that coronary artery disease impacted negatively on AVR outcomes in elderly patients, increasing the operative mortality rate to 9.7% irrespective of the number of coronary vessels involved. Kobayashi et al. [12] found no significant differences in operative mortality rates when patients were stratified according to the number of bypass grafts or the completeness of revascularization. However, they found a significantly higher operative mortality rate among patients with more extensive coronary artery disease. Although concomitant CABG may increase operative risk, this increased risk may be caused by the underlying coronary artery disease. In the present study, the number of diseased vessels was not associated with early major complications, late mortality or late morbidity.
In contrast, some studies found that outcomes were the same or better after AVR with CABG compared with AVR alone [7] [8] [9] . Melby et al. [13] found that concomitant CABG improved operative and long-term outcomes in elderly patients undergoing AVR. They speculated that the difference between their findings and those of previous studies could be explained by improvements in surgical and perioperative care, including improved protection from myocardial ischaemia. Dell'Amore et al. [7] found that operative mortality and mid-term survival rates were almost the same in elderly patients undergoing AVR with and without CABG, although the rates of low-output syndrome and stroke were significantly higher in patients undergoing AVR with CABG. They considered that improved surgical and medical care, careful patient selection and improved revascularization strategies may have influenced the outcomes. In the present study, operative mortality rate (1.9%) and mid-term survival rate (83.1% at 5 years) in elderly patients undergoing AVR with CABG were more favourable than in other studies.
Gall et al. [14] found that use of the internal thoracic artery did not affect operative mortality and improved survival in patients undergoing AVR with CABG. The internal thoracic artery is considered to be the most reliable revascularization graft for diseased coronary arteries because of its long-term durability [15] . The left internal thoracic artery is usually used for revascularization of the left anterior descending coronary artery, even in elderly patients [16] . In the present study, 64% of patients in each group had lesions in the left anterior descending artery. We performed the anastomosis between the internal thoracic artery and the left anterior descending artery after declamping the aorta, using an on-pump beating-heart technique. We used mostly saphenous vein grafts for revascularization of the other coronary arteries. Our revascularization strategies were the same in elderly and non-elderly patients. Mizutani et al. [17] used propensity-matched analysis to demonstrate the safety and effectiveness of on-pump beating-heart CABG compared with conventional CABG. We believe that there are several benefits to performing the anastomosis between the internal thoracic artery and the left internal thoracic artery after declamping of the aorta in patients undergoing AVR with CABG. This technique can shorten the cardiac arrest time and make it easier to determine the optimal length of the internal thoracic artery graft.
Age is one of the most important risk factors in cardiac surgery, including AVR [1, 11, 18] . However, few studies have compared elderly and non-elderly patients undergoing AVR with CABG. Kobayashi et al. [12] studied 233 patients who underwent AVR with CABG and found that age >65 years was a significant predictor of late mortality. Other predictors of late mortality were emergency operation, ejection fraction <0.30, New York Heart Association functional Class III/IV and chronic obstructive pulmonary disease. In contrast, Alsoufi et al. [9] studied 249 patients who underwent AVR with CABG and found that peripheral vascular disease and cerebrovascular disease were significant predictors of late mortality, but age was not. In the present study, diabetes mellitus and higher creatinine level were identified as independent predictors of 5-year all-cause death, but age (as a continuous 
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T. Fukui et al. / European Journal of Cardio-Thoracic Surgeryvariable) was not. In our patients of this study, the Non-elderly group had a higher prevalence of diabetes mellitus and higher creatinine level than the Elderly group. This trend might at least partially explain progressive deterioration of mid-term outcomes in the Non-elderly group and make no difference in survival between the two groups. Moreover, we believe that improvements in surgical techniques, critical care medicine and rehabilitation care may contribute to achieving equivalent outcomes in both elderly and non-elderly patients. The use of internal thoracic artery grafts may also contribute to improved long-term outcomes in both elderly and non-elderly patients [16] .
In the present study, the incidence of re-exploration for bleeding was significantly higher in the Elderly group than in the Non-elderly group. There are some reports demonstrating the higher incidence of re-exploration for bleeding in elderly patients compared with non-elderly patients [19, 20] . Although our result was comparable with these previous reports, the reason for this still needs to be determined.
Study limitations
This study has several limitations. This was a retrospective observational study of patients treated at a single institution. The number of patients was relatively small, and the follow-up period was only 34.9 ± 21.7 months. Furthermore, the number of outcome events was relatively small, and this may make multivariate analysis tenuous.
CONCLUSIONS
The early and mid-term outcomes of combined AVR and CABG were comparable between elderly and non-elderly patients. Older age was not found to be an independent predictor of outcomes, and combined AVR and CABG should be recommended for properly selected elderly patients based on similar indications for non-elderly patients.
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